Medifast (MED) Total Current Liabilities (2010 - 2026)

Medifast has reported Total Current Liabilities for 17 years, with the latest figure at $42.2 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities fell 30.39% year-over-year to $42.2 million; the trailing twelve-month figure through Mar 2026 stood at $42.2 million (down 30.39% YoY), and the FY2025 full-year result was $43.0 million, down 33.04% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $42.2 million, down from $43.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $188.2 million in Q2 2022, with the low at $42.2 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $96.5 million across 5 years, with a median of $77.2 million in 2024.
• Annual changes were most pronounced in 2022 — Total Current Liabilities climbed 24.93% — and 2024, when it tumbled 41.41%.
• Medifast's Total Current Liabilities stood at $140.9 million in 2022, then slumped by 34.49% to $92.3 million in 2023, then sank by 30.49% to $64.2 million in 2024, then slumped by 33.04% to $43.0 million in 2025, then fell by 1.81% to $42.2 million in 2026.
• The last three Total Current Liabilities figures came in at $42.2 million (Q1 2026), $43.0 million (Q4 2025), and $46.7 million (Q3 2025), per Business Quant data.